Insulin resistance and cardiovascular risk in the pediatric patient

Progress in Pediatric Cardiology

Volumn 12, Issue 2, 2001, Pages 169-175

  Steinberger, Julia ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular risk; Children; Insulin; Lipids; Obesity

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; DYSLIPIDEMIA; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

EID: 0035137516     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(00)00070-9     Document Type: Article

References (99)

1. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
2. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
3. Insulin and hypertension
4. Insulin resistance: syndrome or tendency?
5. Epidemiologic features of left ventricular hypertrophy in normotensive and hypertensive subjects
6. The impact of obesity on left ventricular mass and geometry: The Framingham Heart Study
7. Factors of risk in the development of coronary heart disease: six year follow-up experience: the Framingham Study
8. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham Study
9. Electrocardiographic left ventricular hypertrophy and the risk of coronary heart disease: the Framingham Study
10. Prevalence and natural history of electrocardiographic left ventricular hypertrophy
11. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Study
12. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study
13. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults
14. Endocrine and metabolic effects of experimental obesity in man
15. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey
16. The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM
17. Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding
18. Obesity and insulin resistance in man: a dose response study
19. Metabolic basis of obesity and non-insulin dependent diabetes mellitus
20. Mechanism of insulin resistance in human obesity: evidence for receptor and post-receptor defects
21. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians
22. How to measure insulin sensitivity
23. Insulin resistance during puberty: results from clamp studies in 357 children
24. Obesity and cardiovascular disease
25. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study
26. Body weight and mortality. A 26-year follow-up of middle-aged men
27. Weight gain as a risk factor for clinical diabetes mellitus in women
28. Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance?
29. Insulin sensitivity, lipids, and body composition in childhood: is 'syndrome x' present?
30. Co-existence of severe insulin resistance and hyperinsulinemia in pre-adolescent obese children
31. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals
32. Insulin and blood pressure during weight loss in obese adolescents
33. Relationship between insulin resistance and abnormal lipid profile in obese adolescents
34. Insulin resistance, hyperinsulinemia and hypertension
35. Insulin resistance and hypertension
36. Metabolic abnormalities of hypertension. A lesson in complexity
37. Hyperinsulinemia: a link between obesity and hypertension?
38. The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man
39. Renal and cardiovascular effects of exogenous insulin in healthy volunteers
40. Effects of insulin on renal sodium excretion
41. Insulin resistance and hypertension. Connections with sodium metabolism
42. Hyperinsulinemia: possible role in obesity-induced hypertension
43. Effect on insulin on the proliferation of cultured primate arterial smooth muscle cells
44. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance
45. Insulin resistance in essential hypertension
46. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension
47. Hyperinsulinemia and other metabolic disturbances in well-controlled hypertensive men and women: an epidemiological study of the Dalby population
48. Essential hypertension: an insulin-resistant state
49. Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks
50. Fasting serum insulin levels in essential hypertension. A meta-analysis
51. Weight and hypertension
52. Weight and blood pressure
53. Obesity and hypertension: epidemiological and clinical issues
54. The Intersalt Study: relations of body mass index to blood pressure
55. Insulin resistance versus insulin secretion in the hypertension of obesity
56. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study
57. Childhood predictors of high blood pressure
58. Longitudinal prediction of adult blood pressure from juvenile blood pressure levels
59. Familial aggregation and genetic epidemiology of blood pressure
60. Increased familial cardiovascular mortality in obese schoolchildren: the Muscatine ponderosity family study
61. Association of fasting insulin with blood pressure in young individuals: The Bogalusa Heart Study
62. Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks
63. Insulin and renal sodium retention in obese adolescents
64. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents
65. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents
66. Hyperinsulinemia in normotensive offspring of hypertensive parents
67. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis
68. Relationship between lipoprotein levels and in vivo insulin action in normal young white men
69. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women
70. Do upper body and centralization adiposity measure different aspect of regional body fat distribution: relationship to non-insulin dependent diabetes mellitus, lipids and lipoproteins
71. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics
72. Relationship of body fat distribution to metabolic complications of obesity
73. Impact of obesity on metabolism in men and women: importance of regional adipose distribution
74. Reappraisal of the role of insulin in hypertriglyceridemia
75. Role of insulin in endogenous hypertriglyceridemia
76. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride
77. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa heart study
78. Plasma insulin and lipoprotein concentrations: an atherogenic association?
79. Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men
80. Determinants of human adipose tissue lipoprotein lipase: effect of diabetes and obesity on basal and diet induced activity
81. Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity
82. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL
83. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study
84. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity: the Framingham Study
85. Relation of blood pressure and body fluid to left ventricular mass in normotensive and hypertensive employed adults
86. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS)
87. Sex-specific determinants of increased left ventricular mass in the Tecumseh blood pressure study
88. Determinants of cardiac involvement in children and adolescents with essential hypertension
89. Sex differences in the determinants of left ventricular mass in childhood: the Medical college of Virginia twin study
90. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents
91. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: the Bogalusa heart study
92. Relation of left ventricular mass to the insulin resistance syndrome in children
93. Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects
94. Overview of the association between insulin and atherosclerosis
95. Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement
96. Cardiac septal hypertrophy in hyperinsulinemic infants
97. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders
98. Secular trends of blood pressure and body size in a multi-ethnic adolescent population: 1986 to 1996